At what COST?: A prospective longitudinal cohort assessment of financial toxicity, quality of life, and associated risk factors in patients with plasma cell disorders.

Published in: American journal of hematology (2024)

Financial toxicity is prevalent and harmful to patients with plasma cell disorders.

Keyphrases